Position in XERS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$6,313,824
+$28,329 QoQ
Shares Held
797,200
-0.4% QoQ
Ownership
0.437%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#32
of 238 holders
Holding Since
Mar 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XERS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026NORGES BANK holds $2,351,821,288 across 19 Drug Manufacturers - Specialty & Generic names. XERS ranks #12 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
32,299,753 | $1,094,315,631 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
694,753 | $376,438,017 | |
| 3 | ZTS |
Zoetis Inc.
|
4,689,847 | $337,012,405 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
973,880 | $164,137,735 | |
| 5 | ALKS |
Alkermes plc.
|
2,156,814 | $113,017,053 | |
| 6 | HLN |
Haleon plc
|
7,175,000 | $66,942,750 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
586,845 | $65,104,584 | |
| 8 | VTRS |
Viatris Inc
|
3,822,744 | $60,705,174 |
All Filings in XERS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,313,824 | 797,200 | Shares | Sole | 2026-08-12 | |
| 2025-12-31 | $6,285,495 | 800,700 | Shares | Sole | 2026-02-10 | |
| 2025-06-30 | $2,623,139 | 561,700 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $4,522,662 | 823,800 | Shares | Sole | 2026-05-11 | |
| No filing history on record for this holder in this stock. | ||||||